Deceleration capacity: A novel predictor for total mortality in patients with non-ischemic dilated cardiomyopathy.
Int J Cardiol
; 221: 289-93, 2016 Oct 15.
Article
em En
| MEDLINE
| ID: mdl-27404693
ABSTRACT
OBJECTIVES:
We hypothesized that deceleration capacity (DC), a novel marker of cardiac autonomic modulation, is an independent predictor for mortality in patients with non-ischemic dilated cardiomyopathy (NICM).BACKGROUND:
NICM is associated with a high risk for sudden cardiac death (SCD). However there are no clinically established parameters available for risk stratification beyond LVEF. DC has been previously shown to be a strong independent predictor for total mortality in patients after myocardial infarction.METHODS:
Holter-ECG recordings of 201 patients NICM (83.1% male, mean age 61.4years, mean LVEF 33.3%) were analyzed by the method of phase-rectified-signal-averaging (PRSA) to obtain DC.RESULTS:
During a minimum follow-up of 40month 59 patients died. Kaplan Meyer Analysis showed a significantly higher mortality in patients with a DC below 4.5ms (log rank p=0.012) irrespective to the presence of atrial fibrillation.CONCLUSIONS:
Impaired DC is a powerful independent predictor for mortality in patients with NICM.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Dilatada
/
Desaceleração
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article